The Chinese State Food and Drug Administration’s (SFDA) new GMP regulations could result in a restructure of the country’s drug industry. In March 2011, the SFDA announced new GMP regulations, which firms must adhere to by December 2015. Chinese drug exports conform to European, US and Japanese regulations, so Chinese firms that export active pharmaceutical […]
A July survey of 156 chemical industry senior executives found that 63% plan to increase capital spending next year, with 81% of Asian executives expecting to do so. In 2012, 38% of executives expect to invest between 3% to 5% of revenues in R&D, while 31% expect to invest between 2% and 3%. Eighty percent […]
For the first time in three years, Canada’s industrial R&D spending is expected to rise, increasing 0.9% to CAD 15.5 billion ($15.9 billion) in 2012. Spending by the manufacturing sector is estimated to increase 3.1% to account for 49% of total industrial R&D investment. Spending on aerospace products and parts, and drug manufacturing is expected […]
Company Announcements Analytik Jena closed AJ USA in April. Xylem’s second-quarter sales for the Test portion of its Water Infrastructure division grew 58%, including $32 million in YSI sales. First-quarter sales declined 2%, excluding YSI, which had double-digit growth. The UK announced in August the establishment of the Medical Research Council–National Institute for Health Research […]
Patch clamp is a technique used to measure the ionic currents of cells. Traditionally, patch clamp experiments have been performed manually using a single, hollow electrode that is brought into contact with the cellular membrane. Using gentle suction, a tight seal is made between the cell membrane and the electrode, which allows researchers to record […]
Santa Clara, CA 10/8/12—Affymetrix has announced that it expects third-quarter revenues of $80 million, including eBioscience sales of $18 million, based on preliminary financial data. “Based on ongoing concerns about global academic funding as well as a weaker euro, we now believe that total revenue for Affymetrix excluding eBioscience will be flat to slightly down […]
Second-quarter revenues for IBO’s Lab Equipment/Consumables Sales Index improved 0.7%, 2.0% excluding currency, to $4,061 million. Operating profits for the Index rose 4.0% to $737 million. Based on continuing operations, operating margin slipped 30 basis points to 17.9% of sales. For the fiscal third quarter ending August 31, revenue for Gerresheimer Life Science Research grew […]
Stem cell research is steadily moving forward. As the award this month of the Nobel Prize in Medicine to Dr. Shinya Yamanaka, who created the first induced pluripotent stem cells (iPSCs), shows, the ability to create stem cells from somatic cells has changed scientific research. Contributing to the research’s advancement has been rapid progress in […]
R&D investment by the one thousand public companies that spend the most on R&D increased 9.6% in 2011 to $603 billion after a 9.3% increase the previous year, according to Booz & Company’s eighth annual “Global Innovation 1000” report. R&D spending by the computing and electronics, health care and automobile industries accounted for 28%, 21% […]
US, European and Japanese central banks all implemented new economic stimulus strategies this month. The European Central Bank announced plans to buy unlimited government debt, and the Bank of Japan increased its asset purchase program. On September 13, the US Federal Reserve agreed to purchase $40 billion of mortgage securities each month until the economy […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
